Gastric cancer remains a leading cause of cancer-related mortality worldwide despite advances in prevention and systemic therapy. Recent integration of precision oncology has transformed its management, shifting treatment selection toward biomarker-driven strategies. In this context, the gastroenterologist-endoscopist...
Renato Cannizzaro, Fabio Farinati, Valentina Angerilli et al.· Digestive and Liver Disease· 0 citations
Background:
Abnormalities in body composition are common in patients with hepatocellular carcinoma (HCC); however, their impact across different treatment modalities remains poorly understood. We systematically reviewed the prognostic value of body composition in patients with HCC, stratified by curative, locoregional...
Elisa Pinto, B. Barberio, M. Gambato et al.· Hepatology Communications· 0 citations
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, owing to late-stage diagnosis and underlying liver disease that limits curative treatment options. Conventional surveillance and diagnostic strategies relying on imaging and alpha-fetoprotein (AFP) lack sufficient sensitivity, par...
M. Amer, Valeria Tosello, Elisa Pinto· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.